Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetes.
Current opinion in endocrinology, diabetes, and obesity（2023）
Abstract
Clinical trial evidence for lipid-lowering therapies in T1D is lacking, and further studies are needed to inform best practice. Optimization and harmonization of ASCVD risk-stratification and lipid management in individuals with T1D is required.
MoreTranslated text
Key words
cardiovascular diseases,diabetes mellitus type 1,dyslipidaemias,risk factors,statins
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined